Publication Date:
1979-11-02
Description:
Recent studies have shown that heparin is a biochemical representative of a distinct class of compounds known as linear anionic polyelectrolytes. Members of this class are mixtures of individual highly negatively charged chains that show a wide spectrum of specific reactions with biologically active proteins. Upon administration, heparin chains enter a cellular pool and effectively prevent thrombosis by increasing the electronegative potential of the vessel wall. Anticoagulant activity is an unusual feature of a few heparin chains and appears to play a minor role in many clinical uses and in physiological and pathological responses.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Jacques, L B -- New York, N.Y. -- Science. 1979 Nov 2;206(4418):528-33.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/386509" target="_blank"〉PubMed〈/a〉
Keywords:
Antithrombin III/metabolism
;
Blood Coagulation/drug effects
;
Heparin/adverse effects/*pharmacology/therapeutic use
;
Humans
;
Ions
;
Mast Cells/physiology
;
Structure-Activity Relationship
;
Sulfates/metabolism
;
Thrombosis/prevention & control
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink
